...
首页> 外文期刊>Antimicrobial Resistance and Infection Control >Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study
【24h】

Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study

机译:塞尔维亚贝尔格莱德一家三级医院住院的外科手术患者艰难梭菌感染的危险因素:病例对照研究

获取原文

摘要

Background The objective of this study was to investigate independent risk factors (RFs) connected with healthcare-associated (HA) Clostridium difficile infection (CDI) in surgical patients, its frequency per surgical wards and in-hospital-mortality at a single hospital. Methods Risk factors for the infection were prospectively assessed among surgical patients with laboratory confirmed HA CDI and compared with a control group without HA CDI. Results The overall incidence rate of HA CDI was 2.6 per 10000 patient-days. Significant independent RFs for HA CDI were the use of carbapenems ( P =?0.007, OR: 10.62, 95% CI: 1.93–58.4), the admission to intensive care unit ( P =?0.004, OR:3.00, 95% CI:1.41–6.40), and the administration of 3rd generation cephalosporins ( P =?0.014, OR:2.27, 95% CI:1.18–4.39). Patients with HA CDI had significantly higher in–hospital mortality compared to controls ( P : 0.007; OR: 8.95; 95% CI: 1.84–43.43). Conclusions CDI is an important HA infection in population of surgical patients and this study emphasizes the importance of the wise use of antibiotics, and other infection control strategies in order to prevent HA CDI, and to decrease the incidence and in-hospital mortality rate.
机译:背景技术这项研究的目的是调查与外科手术患者的医疗相关(HA)艰难梭菌感染(CDI)相关的独立危险因素(RF),其在每个病房的频率和在一家医院的住院死亡率。方法前瞻性评估实验室确诊为HA CDI的手术患者的感染危险因素,并与无HA CDI的对照组进行比较。结果HA CDI的总发生率为每10000患者日2.6。 HA CDI的重要独立RF为使用碳青霉烯(P =?0.007,OR:10.62,95%CI:1.93-58.4),重症监护病房的入院(P =?0.004,OR:3.00,95%CI: 1.41–6.40)和第三代头孢菌素的使用(P =?0.014,OR:2.27,95%CI:1.18–4.39)。与对照组相比,HA CDI患者的院内死亡率显着更高(P:0.007; OR:8.95; 95%CI:1.84–43.43)。结论CDI是外科手术患者人群中重要的HA感染,这项研究强调了合理使用抗生素和其他感染控制策略对预防HA CDI并降低发病率和院内死亡率的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号